Understand how your state handles generic and biosimilar drug substitutions. Learn when pharmacists can switch your meds, what rights you have, and how to protect your health under state-specific laws.
The FDA extends expiration dates for critical drugs during shortages to prevent supply gaps. This data-driven process ensures patient safety while keeping essential medications available until new production arrives.
Generic combination products combine drugs and devices, but replacing them with generics isn't simple. Even if both parts are generic, they must be approved as a matched system-otherwise, they're not safe or legal substitutes.
Acetaminophen overdose is the leading cause of acute liver failure in the U.S. Learn the silent signs of liver damage, why timing is critical, how NAC saves lives, and how to avoid accidental overdose from common painkillers and cold meds.
The 80-125% rule for generic drugs isn't about ingredient amounts-it's about how your body absorbs the drug. Learn what this standard really means and why generics are just as safe and effective as brand-name drugs.
Statins can cause insomnia and vivid dreams in some people, especially lipophilic types like simvastatin. Switching to pravastatin or atorvastatin often helps. Learn how to tell if your sleep issues are linked to your cholesterol meds-and what to do next.
Generic drugs are just as effective as brand-name drugs for most conditions, saving patients up to 85% on costs. Learn how bioequivalence works, when to be cautious, and why generics are the standard - not a compromise.
Post-marketing pharmacovigilance tracks drug side effects after approval, using real-world data from millions of patients to catch dangers clinical trials miss. Learn how reports, AI, and patient input keep medications safe.
St. John's Wort may help mild depression, but it can make prescription drugs like warfarin, birth control, and antidepressants ineffective - or cause dangerous side effects. Learn which medications are at risk and what to do instead.
Antibiotic shortages are leaving patients without life-saving treatments. Rising resistance, weak manufacturing, and economic neglect are pushing us toward a post-antibiotic era where common infections could become deadly again.